Highlights From the American College of Cardiology’s Scientific Sessions: New Heart Failure Management Guidelines and more

<p>Preventive cardiologist and conference cochair Pamela Morris, MD, discusses new heart failure management guidelines and important clinical trial results presented at the American College of Cardiology’s 2022 Scientific Sessions.</p> <p>Related Content:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5487"> Highlights From the American College of Cardiology’s Scientific Sessions—New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5050"> Short Interfering RNA Targeting Lp(a) Production in Individuals With Elevated Plasma Lp(a)</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5218"> Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5333"> The Potential Clinical Benefit of Lowering Lipoprotein(a)</a></li> </ul>